Evotec International GmbH

Evotec International GmbH is a leading global biotechnology company that focuses on the discovery and development of novel therapeutics. Established with a vision to transform the drug development process, Evotec leverages its extensive expertise in various therapeutic areas, including oncology, neuroscience, and metabolic diseases.

The company operates through a unique business model that combines innovative technology platforms with a collaborative approach to research and development. This enables Evotec to partner with pharmaceutical and biotechnology companies, academic institutions, and other stakeholders to accelerate the drug discovery process.

With a commitment to scientific excellence, Evotec invests heavily in research and development, ensuring that it remains at the forefront of biopharmaceutical innovation. The company’s state-of-the-art facilities are equipped with cutting-edge technologies that facilitate high-throughput screening, compound management, and data analysis.

Evotec’s core activities include:

• Drug Discovery: Identifying and optimizing lead compounds for various therapeutic targets.
• Preclinical Development: Conducting studies to evaluate the safety and efficacy of drug candidates.
• Clinical Development: Supporting partners in the transition from preclinical to clinical trials.

In addition to its research capabilities, Evotec is dedicated to fostering a culture of collaboration and innovation. The company believes that by working together with its partners, it can achieve breakthroughs that will ultimately benefit patients worldwide.

Evotec International GmbH is headquartered in the UK and has a diverse workforce that is passionate about making a difference in the field of medicine. With a strong pipeline of projects and a commitment to advancing healthcare, Evotec is poised to continue its growth as a leader in the biotechnology industry.